| Entry |
|
|---|
| Name |
Pentoxifylline (JAN/USP/INN);
Pentoxil (TN);
Trental (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C13H18N4O3
|
|---|
| Exact mass |
278.1379
|
|---|
| Mol weight |
278.31
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Respiratory system agent
DG01616 Xanthine derivative
DG01614 Xanthine-type vasodilator
|
|---|
| Remark |
|
|---|
| Efficacy |
Vasodilator |
|---|
| Disease |
Chronic occlusive arterial disease [DS: H01629] |
|---|
| Comment |
Xanthine derivative
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C04 PERIPHERAL VASODILATORS
C04A PERIPHERAL VASODILATORS
C04AD Purine derivatives
C04AD03 Pentoxifylline
D00501 Pentoxifylline (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Cardiovascular Agents, Other
Pentoxifylline
D00501 Pentoxifylline (JAN/USP/INN)
Drug groups [BR:br08330]
Respiratory system agent
DG01616 Xanthine derivative
DG01614 Xanthine-type vasodilator
D00501 Pentoxifylline
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C8y C 20.8239 -18.4795
2 C8y C 20.8239 -19.9063
3 C8y C 22.0285 -17.7718
4 N4y N 19.5197 -18.0467
5 N4y N 22.0285 -20.5907
6 N5x N 19.5197 -20.3391
7 N4y N 23.2508 -18.5087
8 O5x O 22.0285 -16.3916
9 C8x C 18.7009 -19.2046
10 C1a C 19.0811 -16.7191
11 C8y C 23.2508 -19.8538
12 C1a C 22.0285 -22.0234
13 C1b C 24.4671 -17.8186
14 O5x O 24.5023 -20.5556
15 C1b C 25.6720 -18.5146
16 C1b C 26.8825 -17.8129
17 C1b C 28.0872 -18.5146
18 C5a C 29.2977 -17.8129
19 C1a C 30.5083 -18.5146
20 O5a O 29.2977 -16.4150
BOND 21
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 1
9 4 10 1
10 5 11 1
11 5 12 1
12 7 13 1
13 11 14 2
14 13 15 1
15 15 16 1
16 16 17 1
17 17 18 1
18 18 19 1
19 18 20 2
20 6 9 2
21 7 11 1
|
|---|
